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Open Forum Infectious Diseases
MAJOR ARTICLE
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Division of Infectious Diseases, Department of Medicine, Washington University School of Medicine in St. Louis, St. Louis, Missouri, USA, 2Bernard Becker Medical Library, Washington University
in St. Louis, St. Louis, Missouri, USA, and 3Department of Medicine, Washington University School of Medicine in St. Louis, St. Louis, Missouri, USA

Background. Health care administrative database research frequently uses standard medical codes to identify diagnoses or
procedures. The aim of this review was to establish the diagnostic accuracy of codes used in administrative data research to identify
nontuberculous mycobacterial (NTM) disease, including lung disease (NTMLD).
Methods. We searched Ovid Medline, Embase, Scopus, Cochrane Database of Systematic Reviews, Cochrane Central Register
of Controlled Trials, and ClinicalTrials.gov from inception to April 2019. We included studies assessing the diagnostic accuracy of
International Classification of Diseases, 9th edition, Clinical Modification (ICD-9-CM) diagnosis codes to identify NTM disease and
NTMLD. Studies were independently assessed by 2 researchers, and the Quality Assessment of Diagnostic Accuracy Studies 2 tool
was used to assess bias and quality.
Results. We identified 5549 unique citations. Of the 96 full-text articles reviewed, 7 eligible studies of moderate quality (3730 participants) were included in our review. The diagnostic accuracy of ICD-9-CM diagnosis codes to identify NTM disease varied widely across
studies, with positive predictive values ranging from 38.2% to 100% and sensitivity ranging from 21% to 93%. For NTMLD, 4 studies reported diagnostic accuracy, with positive predictive values ranging from 57% to 64.6% and sensitivity ranging from 21% to 26.9%.
Conclusions. Diagnostic accuracy measures of codes used in health care administrative data to identify patients with NTM
varied across studies. Overall the positive predictive value of ICD-9-CM diagnosis codes alone is good, but the sensitivity is low;
this method is likely to underestimate case numbers, reflecting the current limitations of coding systems to capture NTM diagnoses.
Keywords. accuracy; administrative data research; ICD codes; nontuberculous mycobacteria; NTM; NTMLD.
Nosology, the branch of medical science that deals with the
classification of diseases, uses codes to standardize reporting
of diseases. The International Classification of Diseases (ICD)
codes endorsed by the World Health Organization are the most
commonly used worldwide. The intention of the codes is to reflect the patient’s true underlying disease, but their accuracy is
highly variable, as the code assignment process is subject to potential sources of error [1–4]. These codes serve administrative
purposes and are routinely collected and abstracted for billing
and to file medical records or registries; they were not designed
specifically for research. In recent years, health care administrative database research has been steadily increasing due to its
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relatively low cost. Administrative data are particularly useful
to study rare disorders with a low incidence. Administrative
data research relies on coded diagnoses and/or procedures [5,
6]. However, relying on single codes or a combination to identify and accurately reflect a diagnosis can potentially lead to
misclassification and erroneous conclusions. This has been recognized by researchers and has led to the validation of several
codes using medical record review as the gold standard [7].
Administrative data research has been particularly useful
for nontuberculous mycobacterial (NTM) disease due to
its low incidence and lack of mandatory public reporting.
Although the true prevalence of NTM disease is unknown,
various studies have estimated changes in the prevalence of
NTM lung disease (NTMLD), which accounts for 90% of
NTM cases [8, 9]. US population-based surveys in the 1980s
estimated the prevalence of NTMLD at 1–2 cases per 100 000
persons [8]. Using data from 4 health care delivery systems,
the average annual period prevalence for 2004–2006 was 5.5
cases per 100 000 persons [10], and most recently a study
using a national managed care claims database estimated
an annual incidence of NTMLD in 2015 of 4.7 per 100 000
person-years and an annual prevalence that year of 11.7 per
100 000 persons [11]. The increase in prevalence reported
Diagnostic Accuracy of ICD Codes to Identify NTM Infection • ofid • 1
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Diagnostic Accuracy of Health Care Administrative
Diagnosis Codes to Identify Nontuberculous Mycobacteria
Disease: A Systematic Review

Research Question

What is the diagnostic accuracy of ICD codes or sets of codes to
identify NTM disease?
METHODS
Data Sources and Search Strategy

A medical librarian (L.H.Y.) searched the literature for records
including the concepts nontuberculous mycobacteria lung
disease (NTMLD), pulmonary nontuberculous mycobacteria
(PNTM), data, databases, and coding. The librarian created
search strategies using a combination of keywords and standardized index terms in Ovid Medline 1946-, Embase 1947-,
Scopus 1823-, Cochrane Database of Systematic Reviews
(CDSR), Cochrane Central Register of Controlled Trials
(CENTRAL), and ClinicalTrials.gov 1997–4/2019. All search
strategies were completed in April 2019, and a total of 9988 results were found. Using Endnote, 4624 duplicate records were
identified by the automatic duplicate finder, and another 420
duplicates were removed manually, resulting in a total of 4944
unique citations included in the project library. Fully reproducible search strategies for each database can be found in the
Supplementary Data. Results were updated on May 14, 2020,
by running searches from database inception to May 14, 2020,
then de-duplicating total results against the original results to
find 605 new citations, to ensure capturing newly published
manuscripts as databases do not always add content linearly.
The PROSPERO registry was searched to corroborate that no
systematic review was available on this topic.
Study Selection

All titles and abstracts were reviewed independently by 2 researchers (C.M.C. and K.M.) for relevance to the research question in the initial screening. To be included in the analysis,
studies had to meet the following inclusion criteria: (1) used
health administrative codes to identify patients with NTM disease including NTMLD, (2) had a reference data set to confirm
the diagnosis of NTM disease, and (3) reported a measure of
2 • ofid • Mejia-Chew et al

diagnostic accuracy (sensitivity, specificity, positive predictive value [PPV], and/or negative predictive value [NPV])
of the code(s) used to identify patients with NTM disease or
had the information available to calculate at least 1 of them.
Manuscripts were excluded if the full-length article was not
published in either English or Spanish and if the code(s) used
to identify NTM was combined with the reference standard (incorporation bias). Inter-rater reliability analysis between the 2
researchers (C.M.C. and K.M.) was performed with crosstabs
and calculation of the kappa statistic using SPSS Software, version 24 (IBM, Armonk, NY, USA).
The reference standard was defined as the data set in which
NTM cases were confirmed using the diagnostic criteria outlined by the American Thoracic Society and Infectious Diseases
Society of America (ATS/IDSA) clinical guidelines for NTM
disease, a combination of clinical (ie, symptoms, radiological
findings, and exclusion of other diagnoses) and microbiological
criteria (ie, positive cultures from ≥3 separate sputum specimens, single lower respiratory tract specimen or culture from
sterile site for extrapulmonary disease) (Supplementary Table
2) [15].
Acceptable reference standards included medical record review, mandatory reported NTM surveillance registries, or a
microbiology report data set. The test data set patients were
identified as having NTM disease using health care administrative diagnostic codes.
Data Extraction and Quality and Bias Assessment

From the full-text articles selected, the following data were abstracted by 1 author (C.M.C.) using the standardized form: citation (first author, publication year, country, and sample size),
health administrative data set (years, population characteristics, and type of data), reference data set, ICD code(s) used, and
measurements of diagnostic accuracy (Table 1).
Data were extracted from all studies that used 1 or more diagnostic codes to identify NTM in a data set. The primary outcome measure was the diagnostic accuracy of the code(s) used
to identify patients with NTM disease. As a secondary outcome,
we examined the diagnostic accuracy of the microbiologic case
definitions for NTMLD. The case definition for NTMLD included microbiologic, radiographic, and clinical criteria. Most
studies only assessed the microbiologic criteria, which are the
most important and generally the most feasible to assess. Due to
the heterogeneity of the data sets, study populations, and accuracy estimates, we did not perform a meta-analysis.
We followed the Preferred Reporting Items for Systematic
Reviews and Meta-Analyses of Diagnostic Test Accuracy Studies
(PRISMA-DTA) guidelines and used the Quality Assessment of
Diagnostic Accuracy Studies 2 (QUADAS-2) checklist to assess the risk of bias for each individual study (Supplementary
Table 3) [16, 17]. The quality and risk of bias of the included
studies were assessed by 3 reviewers (C.M.C., T.C.B., and M.O.).
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in these studies ranged from 7.5% to 8.2% per year [11, 12].
Because NTM disease is relatively rare and unlike tuberculosis, not subject to mandatory reporting in most states, our
current understanding of the epidemiology and geographical
distribution of these infections derives mainly from administrative data research [11–14]. With the increasing prevalence
of NTMLD, it is foreseeable that administrative data research
will continue to address many of the questions that remain
unanswered, hence the importance of assessing the accuracy
of the codes used to identify NTM disease and particularly
NTMLD (Supplementary Table 1) [12, 13]. We aimed to
identify studies that validated specific ICD codes or sets of
codes for NTM disease using a reference population.

2000–2008

Winthrop
et al.
(2011),
n = 89

In- and outpatient

Inpatient
only

In- and outpatient

In- and outpatient

In- and outpatient

Unclear

In- and outpatient

Type of Administrative
Database

Cohort 2: all patients in the Portland VA Medical Center database

Cohort 1: RA patients on TNF-α inhibitors from Kaiser Permanente
Northern California

Hospitalized patients in the New England VA electronic database

Cohort 1: All patients in the Miami VA medical database
Cohort 2: All patients in the University of IL at Chicago Medical
Center

All patients in the Premier Healthcare Billing Database

All patients in 4 integrated health care delivery systems (Kaiser
Permanente Southern California, Pasadena, CA, USA; Group
Health, Seattle, WA, USA; Kaiser Permanente Colorado, Denver,
CO, USA; Geisinger Danville, PA, USA)

HIV-negative adults treated for pulmonary MAC by Infectious Diseases and/or Pulmonology Medicine

All COPD patients in the VA Corporate Data Warehouseb

Study Population

Medical record
review of all
cases

Medical record
review of all
cases

Medical record
review of all
cases

Microbiology report
data set

Medical record
review of
large sample
(n = 1561)

Medical record
review of all
cases

Medical record review of random
sample (n = 148)

Reference/Gold
Standard

031.X

031.X

031.0

031.0

031.0

031.0

031.X
(excluded
031.8;
31.9)

ICD-9-CM
Diagnosis
Codesa

65 (53–76)

50 (26–74)

—

—

21

26.9

—

42.9
(12.8–71.5)

Sn
(95% CI),
%

—

—

70
(42– 98)

82 (48–98)
74 (62–85)

—

—

—

—

>99
(>99.9)

Sp
(95%
CI), %

64.6

57

38.2
(15.8–73.4)

PPV
(95% CI),
%

—

—

—

—

—

—

>99.9
(>99.9)

NPV
(95%
CI), %

This included all Veterans Integrated Service Networks regions.

Use of 1 or more ICD-9 codes in any position.

b

a

Abbreviations: COPD, chronic pulmonary obstructive disease; ICD, International Classification of Diseases; ID, Infectious Diseases; MAC, Mycobacterium avium complex; NPV, negative predictive value (true negatives/all negatives); NS, not specified; PPV,
positive predictive value (true positives/all positives); RA, rheumatoid arthritis; Sn, sensitivity (true positives/true positives + false negatives); SP, specificity (true negatives/true negatives + false positives); VA, Veterans Affairs.

2001–2004

2009–2013

Ricotta et al.
(2018),
n = 1326

Schneeweiss
et al.
(2007),
n = 10

1994–2007

Prevots et al.
(2010),
n = 1865

2010–2015

1993–2006

Plotinsky
et al.
(2013),
n = 72

Schweitzer
et al.
(2017),
n = 220

2008–2012

Data
Years

Jones et al.
(2018),
n = 6031

Study
(Year), No.
of Patients

Table 1.   Summary of Validation Studies to Identify Nontuberculous Mycobacteria Disease Using US Health Administrative Databases Using ICD-9 Code Alone
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We used Endnote X8 (Rutgers University, New Brunswick, NJ,
USA) to maintain the reference lists.
RESULTS
Study Characteristics

Identification

9974 citations identified through
database searching (Embase 3903,
Medline 2669, Scopus 3256, and
Cochrane 146)

14 additional records identified
through ClinicalTrials.gov

Duplicate records removed (n = 5044)

Screening

Unique citations: titles/abstracts screened
(n = 4944)
Search update:
New unique citations
(n = 605)

Excluded (n = 5453)

Full-text articles assessed for
eligibility (n = 96)

Included

Eligibility

Studies excluded (n = 89):

Figure 1.

• Conference abstract with
incomplete information (n = 42)
• Incomplete/unclear definition of
NTM infection (n = 5)
• No reference standard group
(n = 40)
• lCD codes not used to define
NTM infection (n = 2)

Final studies included in the
review (n = 7)

Flow diagram for study screening and article inclusion. Abbreviations: ICD, International Classification of Diseases; NTM, nontuberculous mycobacterial.
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After removal of duplicate results, we identified 5549 unique
citations. For the initial screen, articles were considered
relevant to the research question if they referred to human
subjects research and used health care databases, claims,
or population-based data to identify cases of NTM disease.
After review of the titles and abstracts, we identified 96
citations that used claims or billing data to define cases of
NTM disease. The inter-rater reliability between C.M.C. and
K.M. was excellent (Kappa 0.861), and disagreement on the
articles selected was resolved by consensus. After a review
of titles and abstracts, 96 were selected for full-text review,

of which 89 were excluded and 7 were selected as eligible for
this review (Figure 1).
We identified 7 studies for full review that reported at least 1
diagnostic accuracy measure used in an algorithm to identify
patients with NTM disease (Table 1). Only Schweitzer’s study
clarified in their methods the diagnostic position of the ICD
codes used to identify patients [7]. Of the 7 full-text articles,
4 specifically looked at NTMLD, with Plotinsky’s and Ricotta’s
studies further limiting the study sample to only patients with
culture-confirmed pulmonary Mycobacterium avium complex
(MAC) disease [18]. The study population varied significantly
among studies, and 4 of the studies used data from US veterans
to determine the diagnostic accuracy measures and had a predominantly male and older population not representative of
the general population. Plotinsky’s study selected patients managed exclusively by Infectious Diseases or Pulmonary Medicine

Primary Outcome: Validity of the Codes Used to Identify NTM Disease

Algorithms and diagnostic accuracy outcomes to identify NTM
disease using ICD-9-CM diagnosis codes varied across studies,
with sensitivity ranging from 21% to 93% and PPV ranging from
38.2% to 100% (Tables 1 and 2). The sole use of ICD-9-CM code
031.0 by Ricotta et al. also yielded a low sensitivity (21%). Only
2 studies reported diagnostic accuracy for the combination of
ICD-9-CM codes plus microbiological data vs the ICD-9-CM
code alone. In Winthrop’s VA cohort (n = 71), sensitivity decreased when ≥1 culture positive for NTM spp. was required
together with the ICD-9 code 031.X (65% vs 42%). However,
Jones et al. found a substantial increase in sensitivity with the
use of microbiological data or the ICD-9-CM diagnosis code
compared with the ICD-9-CM diagnosis code alone (93% vs
42.9%, respectively), although the increase in the PPV of using
both was only modest (54.3% vs 38.2%). However, PPVs of
ICD-9-CM codes alone to identify NTM cases were consistently
higher in Schneeweiss et al. (70%), Schweitzer et al. (64.6%),
and Winthrop et al. (74%–82%). In Winthrop et al., when both
microbiological and ICD-9-CM codes were used, the PPV was
similar to that of using the ICD-9-CM code alone (77%–90%).
Jones and colleagues reported the specificity and NPV of
using ICD-9 codes to identify NTM cases; both were >99.9%
[14]. Only Winthrop’s study looked at the diagnostic accuracy
of incorporating prescriptions of drugs used to treat NTM infections in their algorithm. The combination of an ICD-9-CM
code plus ≥30 days of a macrolide prescription had the highest
PPV (100%) to identify NTM cases. Also, 1 of the cohorts of
patients included in Winthrop’s study included only patients
with rheumatoid arthritis, limiting the generalizability of their
results.

Secondary Outcome: Validity of the Codes Used to Identify NTMLD

Four studies provided diagnostic accuracy measures for using
the ICD-9-CM code 031.0 to identify NTMLD, with sensitivity
ranging from 21% to 26.9% and PPV ranging from 57% to 64.6%
(Table 1). The lowest sensitivity was seen in Ricotta’s study, in
which those with disease that was microbiologically confirmed
and those with an ICD-9-CM code were compared with the reference standard. This is consistent with previously published
data that only 27% of microbiologically confirmed cases are
coded for NTMLD, suggesting substantial undercoding of this
diagnosis in health care administrative data [19].
Quality Assessment of Studies

The quality of the diagnostic accuracy studies included was
assessed using the revised QUADAS-2 tool across 4 domains:
patient selection, index test, reference standard, and flow
and timing. The overall risk of bias in patient selection was
judged to be low, as all but 1 article included consecutive cases
and there were no inappropriate patient exclusions (Table 3).
Plotinsky et al. only included patients who had been seen by a
Pulmonologist or an Infectious Diseases specialist. In terms of
flow and timing, there was a low risk of bias, given the retrospective nature of the studies and that the accuracy of identification using ICD-9-CM codes was compared with the same
reference standard, the ATS/IDSA diagnostic criteria for NTM
infection. However, 2 studies may be at risk of bias with regard
to interpretation of the reference standard because they used 1
or 2 of 3 components of the reference standard instead of the full
criteria. Ricotta and colleagues used only the microbiological
culture criteria of the ATS/IDSA criteria as their gold standard
to define NTM infection, whereas Prevots et al. lacked data on
the clinical component in their reference data set, and only 81%
of their cohort had radiological information. However, microbiological data have the highest PPV of the 3 criteria.
One of the major risks for bias is the applicability of studies
that broadly used the entire range of ICD-9-CM codes 031.X for
NTM infection and did not differentiate coding for disseminated infection (ICD-9-CM code 031.2) from the NTMLD code
031.0. The underlying predisposing risk factors and prognosis
of disseminated vs NTMLD are quite distinct, with disseminated NTM being an acute and potentially life-threatening condition more frequently encountered in the hospital setting and
NTMLD being an indolent, chronic condition often seen in the
ambulatory setting. Indeed, coding accuracy tends to be lower
in the outpatient setting [20]. Another potential source of bias
is the position of the diagnostic code (ie, primary vs secondary
diagnosis), which was specified in only 1 of the studies included
in the final review. There is evidence that many comorbidities
tend to be underreported and that omission rates for coding of
secondary diagnoses are higher in the outpatient setting [21].
This is often related to a limited number of codes that can recorded in billing claims.
Diagnostic Accuracy of ICD Codes to Identify NTM Infection • ofid • 5
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specialists, and Schneeweiss et al. selected only hospitalized
patients.
Three studies used the presence of the ICD-9-CM diagnosis
code 031.X in their algorithm to identify patients with NTM
disease, but Jones et al. excluded ICD-9-CM diagnosis codes
031.8 and 031.9 (not specific to NTM). Four studies only used
ICD-9-CM diagnosis code 031.0 (pulmonary NTM). Of the
4 studies that relied solely on ICD-9-CM diagnosis codes to
screen patients for inclusion in their cohort, 3 did full chart review on the whole cohort and Jones et al. used a randomized
sample to serve as the reference data set. Winthrop et al. used either positive microbiological cultures or an ICD-9-CM code to
identify eligible patients for their cohort, whereas Prevots’s and
Ricotta’s studies used culture results to establish theirs. Prevots’s
reference data set also lacked clinical data to fully assess ATS/
IDSA NTM diagnostic criteria as the gold standard, and instead
used only microbiological (≥2 sputum samples positive for an
NTM spp. or a single positive culture from a bronchoscopy) and
radiological criteria (available in 81% of the cohort) to verify
NTM disease.

50 (26–74)

42 (31–55)
34 (23–46)

ICD-9-CM diagnosis code + culture
ICD-9-CM diagnosis code + azithromycin/clarithromycin therapy
≥30 d

65 (53–76)
76 (65–85)

ICD-9-CM diagnosis code 031.X

50 (26–74)

100 (81–100)

≥1 culture positive for NTM spp. (excluding M. gordonae)

ICD-9-CM diagnosis code + culture

≥1 culture positive for NTM spp. (excluding M. gordonae)b

—

—

Cultures might have been done elsewhere and discovered during chart review rendering an Sn below 100%.

Definite NTM case: ≥2 sputum cultures positive for NTM spp. or single BAL/biopsy sputum cultures positive for NTM spp.

b

a

—

—

—

—

—

—

—

>99
(>99.9)

>99
(>99.9)

>99
(>99.9)

Sp (95%
CI), %

Abbreviations: ICD, International Classification of Diseases; NLP, natural language processing; NPV, negative predictive value; PPV, positive predictive value; Sn, sensitivity; SP, specificity.

Cohort 2: veterans, n = 71

Cohort 1: Patients with
rheumatoid arthritis, n = 18

ICD-9-CM diagnosis code 031.X

≥1 hospitalization coded ICD-9-CM diagnosis code 031.X as the
primary diagnosis

Schneeweiss et al. (2007),
n = 10

Winthrop et al. (2011), n = 89

≥1 encounter with ICD-9-CM diagnosis code 031.0

79
21

ICD-9-CM diagnosis code 031.0

Schweitzer et al. (2017),
n = 220

NA

≥1 positive culture + ≥1 ICD-9-CM diagnosis code 031.0
≥2 cultures from a pulmonary source positive for MAC

26.9

ICD-9-CM diagnosis code for pulmonary MAC (031.0)

Ricotta et al. (2018), n = 1326

—
47

ICD-9-CM diagnosis code for pulmonary MAC (031.0)

93 (65.9–100)

ICD-9-CM diagnosis code or natural language processing to identify
NTM species from microbiology reports (excluding M. gordonae)
≥1 sputum culture positive for NTM spp.a

84.6 (54.6–100)

Natural language processing to identify NTM species from microbiology reports (excluding Mycobacterium gordonae)

Plotinsky et al. (2013), n = 72

42.9 (12.8–71.5)

≥1 ICD-9-CM diagnosis code 031.0, 031.1, 031.2 (excluding 031.8
and 031.9)

Sn (95% CI), %

Prevots et al. (2010), n = 1865

Jones et al. (2018), n = 148

Algorithm Applied to Identify the Population

>99.9
(>99.9)
>99.9
(>99.9)
—
—

—
—
—

68 (45.9–90.1)
54.3 (33–77.1)
57
—

—
64.6
70 (42–98)

78 (56–93)

100 (86–100)

77 (61–89)

41 (32–50)

74 (62–85)

90 (56–100)
—

—

>99.9
(>99.9)

38.2 (15.8–73.4)

82 (48–98)

NPV (95%
CI), %

PPV (95%
CI), %

Diagnostic Accuracy Measures

Diagnostic Accuracy Measures of Different Algorithms Used to Identify Nontuberculous Mycobacteria Disease Using US Health Administrative Databases

Study (Year), No. of Patients
in the Reference Data Set

Table 2.
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Low
Winthrop, 2011

Abbreviation: QUADAS-2, Quality Assessment of Diagnostic Accuracy Studies 2.

Low

Low
Low
High
Low
Low

Low

Low
Schneeweiss, 2007

Low

Low
High
Low
Low

High

Low
Schweitzer, 2017

Low

Low
Low
Low
Low

High

Low
Ricotta, 2018

Low

Low
Low
Low
High

Low

Low
Prevots, 2010

Low

Low
Low
Low
High

Low

High
Plotinsky, 2013

Low

Low
High
Low
Low

Reference Standard

Low
Jones, 2018

Low

Low

Index Test
Patient Selection

High
Low

Flow and Timing
Reference Standard
Patient Selection
Study

Index Test

Low

Applicability Concerns
Risk of Bias

Quality Assessment of Risk of Bias Among Included Studies Using QUADAS-2
Table 3.
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To our knowledge, this is the first systematic review to summarize the published literature on the diagnostic accuracy of
ICD-CM codes to identify patients with NTM infections in
health care administrative databases. Of the 7 studies that met
eligibility criteria, only 3 had among their aims to validate the
ICD-9-CM code for NTM infection against a reference data
set. The rest of the studies reported at least 1 diagnostic accuracy measure for such codes as a secondary measure. Overall,
the sensitivity of ICD codes in NTM infections was low
(<50%) in 3 of the 4 studies that provided this measure, with
the highest sensitivity (65%) seen in a cohort of US veterans.
The highest sensitivity (93%) and specificity (>99.9%) to detect
NTM cases, seen in Jones et al. study, were achieved through
an algorithm involving either ICD-9-CD codes (031.0, 031.1,
or 031.2) or microbiology results obtained via natural language
processing to identify NTM species, a novel approach to obtain
information about NTM cultures. These findings reflect substantial undercoding of NTM infections in which patients need
to meet clinical, microbiological, and often radiological criteria to establish an NTM diagnosis. It is unclear why the Jones
study produced the lowest PPV, but exclusion of ICD-9 codes
031.8 and 031.9 could have left out true infections that were
erroneously coded through the patient’s trajectory through the
health care encounter [1]. Also, low PPV of a single ICD-CM
code(s) assigned at discharge has been described in other infections in which microbiological or radiological confirmation
to establish a diagnosis is more complicated (eg, cellulitis) [4],
something that might impact identification of NTM infections, where there is typically a time delay between sampling
collection and culture positivity due to the slow-growing nature of NTM.
The different populations included in each study may limit
the generalizability of their results. Jones et al. and Schneeweiss
and colleagues exclusively looked at US Veterans Affairs patients, and in Winthrop et al. and Schweitzer and colleagues’
cohorts, US veterans represented more than 50% of the patients.
This overrepresentation of the US veteran population does not
reflect the general population, as veterans tend to be older, to
have a higher prevalence of comorbidities, and are predominately male [22], limiting the external validity of these studies.
This is important, given that the prevalence of NTM infection
seems to be higher among females in almost all age groups
[23]. The low sensitivity of the ICD-9-CM code 031.0 reported
by Ricotta et al., who used the Premier Healthcare Database,
a billing database that includes privately and publicly insured
patients and also uninsured patients, may be more representative of the general US population. None of the studies included
Medicare data to validate the screening algorithms to identify
patients with NTM infections, an important population given
that the prevalence of NTM infections, particularly NTMLD,
increases dramatically after age 50 and peaks around age

Low

DISCUSSION
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70 years [23]. However, the population included in all studies
was primarily older, supporting the observed findings.
There are several limitations to our review. First, the generalizability of the findings described in most studies is limited to
that of the population being studied, which in half of the studies
included only US veterans. Second, none of the studies included
ICD-10-CM codes for NTM infections. Therefore, a validation
cohort study assessing the sensitivity and specificity of the ICD10-CM code A31.X by investigating a random selection of a large
number of inpatient and outpatient medical records should be
undertaken in the future to clarify the diagnostic accuracy of
that code. Third, only 1 study alluded to the differences in the
diagnostic coding field location (primary, secondary, or all), a
relevant source of misclassification, as comorbidities tend to be
underreported and omission rates for coding of secondary diagnoses tend to be higher in the outpatient setting [20]. Finally, risk
of misclassification with regard to the reference standard was
high in 2 studies that did not use the full ATS/IDSA diagnostic
criteria, primarily due to the lack of clinical or radiological data.
In conclusion, ICD-9-CM codes alone have poor sensitivity
for identifying confirmed NTM cases, potentially missing a relevant number of NTM cases and thereby underestimating the
prevalence of this disease, but they are commonly used because
they are more readily available compared with microbiological
data. However, their good PPV is reassuring, as research done on
populations identified using ICD-9CM codes will most likely obtain relevant clinical conclusions applicable to patients with NTM
infection. The composite use of microbiological data and ICD9-CM codes may increase sensitivity without meaningfully changing the PPV, an approach that should be favored if culture data
are available. Although accuracy of diagnoses based on claims
data may have potential bias due to patient misclassification,
given the low, albeit increasing prevalence of NTM infections,
use of health care administrative data sets remains appealing and
advantageous to estimate epidemiological trends and examine
mortality outcomes. Future studies are needed to address the accuracy of these codes in different health care settings (inpatient vs
outpatient), code positions (primary vs secondary), administrative databases (eg, Medicaid), and ICD-10-CM systems.

